Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.38 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.37 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.37 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.37 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3218635 | 0.85 | GAA (0.45) | GAAKCNA3THRBCYSLTR1PPARG | |
| Flupyrsulfuron SCHEMBL3220772 | 0.84 | GAA (0.47) | GAAKCNA3THRBCYSLTR1PPARG | |
| SCHEMBL3225612 | 0.84 | GAA (0.46) | GAAKCNA3THRBCYSLTR1PPARG | |
| SCHEMBL3262147 | 0.84 | GAA (0.49) | GAAKCNA3THRBCYSLTR1PPARG | |
| Ethoxysulfuron SCHEMBL3221565 | 0.83 | GAA (0.45) | GAATHRBCYSLTR1PPARGEPHX2 | |
| SCHEMBL3228011 | 0.83 | GAA (0.43) | GAAKCNA3THRBCYSLTR1PPARG | |
| SCHEMBL3207655 | 0.82 | GAA (0.45) | GAATHRBALDH1A1RXFP1MAPT | |
| Halosulfuron SCHEMBL3228102 | 0.82 | GAA (0.44) | GAAKCNA3THRBCYSLTR1PPARG | |
| Rimsulfuron SCHEMBL3229754 | 0.82 | GAA (0.46) | GAAKCNA3THRBCYSLTR1PPARG | |
| Sulfometuron SCHEMBL3226563 | 0.81 | THRB (0.50) | GAAKCNA3THRBCYSLTR1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234227-A1 | MICROEMULSION CONCENTRATES | BAYER CROPSCIENCE AG (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100048516-A1 | PENETRATION ENHANCER FOR FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
| US-20080176746-A1 | avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate | BAYER CROPSCIENCE AG (DE) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048516-A1 | PENETRATION ENHANCER FOR FUNGICIDES | DDT, DCPS, TYMP | GAA 430/4885KCNA3 1522/4885THRB 1179/4885 |
| US-20080176746-A1 | avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate | LIPA, MGLL, ABHD6 | GAA 305/4885KCNA3 4830/4885THRB 2225/4885 |
| US-20100234227-A1 | MICROEMULSION CONCENTRATES | ADH1C, MGLL, ADH1A | GAA 1835/4885KCNA3 3382/4885THRB 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.